Suppr超能文献

脐带血清对干眼症的治疗作用:一项系统评价与Meta分析

Therapeutic Effects of Umbilical Cord Serum for Dry Eye Disease: A Systemic Review and Meta-Analysis.

作者信息

Li Bo Da, Jiang Jia Xuan, Zhang Qi, Chu Yi Ran, Chen Ze Ying, Hu Kai

机构信息

Department of Ophthalmology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.

Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

出版信息

Ophthalmic Res. 2025;68(1):71-83. doi: 10.1159/000542731. Epub 2024 Dec 2.

Abstract

INTRODUCTION

Dry eye disease (DED) is a prevalent ocular condition that significantly impacts quality of life. Umbilical cord serum (UCS) has emerged as a promising therapeutic option, but its efficacy requires further investigation. This systemic review and meta-analysis aimed to evaluate the therapeutic effects of UCS eye drops in the treatment of DED.

METHODS

A comprehensive literature search was conducted across multiple databases, including PubMed, Web of science, Embase, Science Direct, Cochrane Library, and China National Knowledge Network, to identify relevant clinical trials. The efficacy of UCS was assessed based on key outcome measures, such as the ocular surface disease index (OSDI), tear break-up time (TBUT), Schirmer I test, and corneal fluorescein staining scores. Meta-analyses were performed to pool the results, and the findings were presented in a forest plot.

RESULTS

Eight studies were included in the meta-analysis, with two relevant randomized controlled trials (RCTs) involving a total of 204 patients. Most of the included studies had a follow-up time of less than 2 months. The pooled results showed that UCS treatment significantly improved the OSDI, with a mean difference (MD) of -9.16 (95% confidence interval [CI], -12.0, -6.36) compared to baseline. Additionally, the TBUT values were higher in the UCS group, with an MD of 2.65 (95% CI, 0.93, 4.36). The Schirmer I test results showed an improvement, with an MD of 1.18 (95% CI, 0.30, 2.06). The fluorescein staining score were also lower in the UCS treatment group, with an MD of -4.71 (95% CI, -5.72, -3.69).

CONCLUSION

This meta-analysis suggested that UCS eye drops had a beneficial therapeutic effect on DED, significantly improving the OSDI, TBUT, Schirmer I test, and corneal fluorescein staining scores. However, larger RCTs with longer follow-up periods were needed to further evaluate the long-term efficacy and safety of UCS in the management of DED.

摘要

引言

干眼症(DED)是一种常见的眼部疾病,严重影响生活质量。脐带血清(UCS)已成为一种有前景的治疗选择,但其疗效仍需进一步研究。本系统评价和荟萃分析旨在评估UCS滴眼液治疗DED的疗效。

方法

在多个数据库中进行全面的文献检索,包括PubMed、Web of science、Embase、Science Direct、Cochrane图书馆和中国知网,以识别相关的临床试验。基于关键结局指标评估UCS的疗效,如眼表疾病指数(OSDI)、泪膜破裂时间(TBUT)、Schirmer I试验和角膜荧光素染色评分。进行荟萃分析以汇总结果,并在森林图中呈现研究结果。

结果

八项研究纳入荟萃分析,两项相关的随机对照试验(RCT)共涉及204例患者。大多数纳入研究的随访时间少于2个月。汇总结果显示,与基线相比,UCS治疗显著改善了OSDI,平均差值(MD)为-9.16(95%置信区间[CI],-12.0,-6.36)。此外,UCS组的TBUT值更高,MD为2.65(95%CI,0.93,4.36)。Schirmer I试验结果有所改善,MD为1.18(95%CI,0.30,2.06)。UCS治疗组的荧光素染色评分也更低,MD为-4.71(95%CI,-5.72,-3.69)。

结论

本荟萃分析表明,UCS滴眼液对DED具有有益的治疗效果,显著改善了OSDI、TBUT、Schirmer I试验和角膜荧光素染色评分。然而,需要更大规模、随访期更长的RCT来进一步评估UCS在DED治疗中的长期疗效和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ca9/11844691/a95769ca1901/ore-2025-0068-0001-542731_F01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验